Bergur V. Stefánsson
- Nephrology top 0.2%
- Chronic Kidney Disease and Diabetes 16
- Renal Diseases and Glomerulopathies 8
- Dialysis and Renal Disease Management 6
-
- Diabetes Treatment and Management 40
- Diabetes Management and Research 13
- Surgery top 2%
- Pancreatic function and diabetes 17
- Transplantation top 5%
-
- Metabolism, Diabetes, and Cancer 11
-
- Erythropoietin and Anemia Treatment 6
- Co-authors
- Hiddo J.L. HeerspinkC. David SjöströmDavid C. WheelerPeter RossingGlenn M. ChertowRicardo Correa‐RotterJohn J.V. McMurrayTom Greene
- Journals
- Journal of the American Society of Nephrology (8 papers)Kidney International Reports (6 papers)Nephrology Dialysis Transplantation (5 papers)
- Partner nations
- SwedenUnited StatesNetherlands
In The Last Decade
Bergur V. Stefánsson
57 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Nephrology 2.1k
- Endocrinology, Diabetes and Metabolism 3.8k
- Cardiology and Cardiovascular Medicine 1.0k
- Surgery 1.6k
- Transplantation 78
Countries citing papers authored by Bergur V. Stefánsson
This map shows the geographic impact of Bergur V. Stefánsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bergur V. Stefánsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bergur V. Stefánsson more than expected).
Fields of papers citing papers by Bergur V. Stefánsson
This network shows the impact of papers produced by Bergur V. Stefánsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bergur V. Stefánsson. The network helps show where Bergur V. Stefánsson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bergur V. Stefánsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 35 | |
| 2 | 2022 | 9 | |
| 3 | Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease | 2021 | 80 |
| 4 | 2021 | 62 | |
| 5 | 2021 | 126 | |
| 6 | 2021 | 22 | |
| 7 | A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathybreakdown → | 2021 | 237 |
| 8 | 2021 | 50 | |
| 9 | 2020 | 32 | |
| 10 | 2020 | 100 | |
| 11 | 2019 | 33 | |
| 12 | 2018 | 74 | |
| 13 | 2017 | 10 | |
| 14 | 2017 | 10 | |
| 15 | 2015 | 46 | |
| 16 | 2012 | 20 | |
| 17 | 2011 | 1 | |
| 18 | 2010 | 23 | |
| 19 | 2005 | 9 | |
| 20 | 2000 | 18 |
About Bergur V. Stefánsson
Bergur V. Stefánsson is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Hematology, having authored 57 papers that have together received 5.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (40 papers), Pancreatic function and diabetes (17 papers), Chronic Kidney Disease and Diabetes (16 papers), Diabetes Management and Research (13 papers), Metabolism, Diabetes, and Cancer (11 papers), Renal Diseases and Glomerulopathies (8 papers), Dialysis and Renal Disease Management (6 papers) and Erythropoietin and Anemia Treatment (6 papers). The work is most often cited by research in Nephrology (2.1k citations), Endocrinology, Diabetes and Metabolism (3.8k citations) and Cardiology and Cardiovascular Medicine (1.0k citations). Bergur V. Stefánsson has collaborated with scholars based in Sweden, United States and Netherlands. Frequent co-authors include Hiddo J.L. Heerspink, C. David Sjöström, David C. Wheeler, Peter Rossing, Glenn M. Chertow, Ricardo Correa‐Rotter, John J.V. McMurray, Tom Greene, Fan Fan Hou and Johannes F.E. Mann. Their work appears in journals such as Journal of the American Society of Nephrology, Kidney International Reports, Nephrology Dialysis Transplantation, Diabetes Obesity and Metabolism and The Lancet Diabetes & Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.